# Chemomab Therapeutics Ltd.: Form 6-K, filed Mar 7, 2024

- Company: [Chemomab Therapeutics Ltd.](/companies/cmmb.md) (CIK 1534248)
- Form: 6-K
- Filed: 2024-03-07
- Accepted by EDGAR: Mar 7, 2024, 07:00 ET
- Period: 2024-03-07
- Accession: 0001178913-24-000856
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1534248/000117891324000856/zk2431109.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1534248/000117891324000856/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1534248/000117891324000856/zk2431109.htm

Filed Mar 7, 2024.
Source: SEC EDGAR, the filing index for accession 0001178913-24-000856. Last ingested by Listed: Nov 3, 2026, 08:33 ET. No prices; not investment advice.